Paclitaxel and Alisertib in Recurrent Ovarian Cancer Reply

Falchook, G; Coleman, RL; Schilder, RJ

Falchook, G (reprint author), HealthONE, Sarah Cannon Res Inst, Drug Dev Unit, 1800 Williams St,Ste 300, Denver, CO 80218 USA.

JAMA ONCOLOGY, 2019; 5 (6): 910